 Singular Genomics Systems Inc NASDAQ:OMIC launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter of 2022, according to BofA Securities. The Singular Genomics Systems Analyst: Michael Ryskin upgraded the rating for Singular Genomics Systems from Neutral to Buy, while keeping the price target unchanged at 21. 